Cargando…
SARS-CoV-2 IgG antibody responses in New York City
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a strain of coronavirus that causes coronavirus disease 2019 (Covid-19) and has been declared a global pandemic by the World Health Organization. Total cases of SARS-CoV-2 worldwide exceed 10.2 million, with over 503,000 deaths recorded...
Autores principales: | Reifer, Josh, Hayum, Nosson, Heszkel, Benzion, Klagsbald, Ikey, Streva, Vincent A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372255/ https://www.ncbi.nlm.nih.gov/pubmed/32777699 http://dx.doi.org/10.1016/j.diagmicrobio.2020.115128 |
Ejemplares similares
-
False positive Herpes Simplex IgM serology in COVID-19 patients correlates with SARS-CoV-2 IgM/IgG seropositivity
por: Vandervore, Laura, et al.
Publicado: (2022) -
Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG
por: McAulay, Kathrine, et al.
Publicado: (2020) -
Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia
por: Megasari, Ni Luh Ayu, et al.
Publicado: (2023) -
Reliable estimation of SARS-CoV-2 anti-spike protein IgG titers from single dilution optical density values in serologic surveys
por: Andrade Belitardo, Emilia M.M., et al.
Publicado: (2022) -
Presence of SARS-CoV-2 antibodies following COVID-19 diagnosis: a longitudinal study of patients at a major urgent care provider in New York
por: Poehlein, Emily, et al.
Publicado: (2022)